4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-24-002380
Options or other derivatives
- PRESIDENT acquired 145,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ryan Charles S. PRESIDENT | 2024-02-01 | Grant or award · Employee Stock Option (right to buy) | +145,000 | 145,000 | D | ||
Loading xslF345X05/form4-02022024_110255.xml…